Amazon S3 on MSN
The real sounds of space captured by NASA
NASA has captured unsettling cosmic noises — from black hole vibrations to Martian winds and Saturn’s rings — despite space’s ...
Tokyo's benchmark Nikkei 225 index has fallen more than 4% and other shares in Asia also sank after a retreat on Wall Street ...
inews.co.uk on MSN
Covid jabs gave under-18s heart problems – but were less risky than catching virus
The health impact of a Covid infection was higher than the risks from the vaccine for teens and children - but it won't ...
Pfizer is one of the world's largest pharmaceutical companies. It has a few material patent expirations on the horizon. It's doing what it has to do to deal with that headwind and others. Pfizer is ...
Pfizer's oncology portfolio has produced a second positive phase 3 trial in HER2-positive breast cancer in the span of about a year. This time, the drug that delivered the positive readout is Tukysa, ...
For the second year running, Pfizer has arrived at the European Society for Medical Oncology (ESMO) conference armed with data showing its one-time heart failure hopeful ponsegromab can treat a ...
The U.S. pharmaceutical industry needs to collaborate with China, given the country's relatively faster drug development, Pfizer (NYSE:PFE) CEO Albert Bourla said at an event on Tuesday. "In biopharma ...
Pfizer evelops and markets branded medicines, vaccines, and biosimilars across therapeutic areas such as cardiovascular, oncology, infectious diseases, and immunology. The company generates revenue ...
This trial tested a new treatment for patients with a type of breast cancer (metastatic breast cancer (MBC)) that is positive for HER2, which means the cancer cells have a specific protein that helps ...
Women who use Depo-Provera face a higher risk of developing a slow-growing brain tumor, according to a new study that comes as the contraceptive’s maker, Pfizer, faces hundreds of lawsuits claiming ...
Pfizer Chief Executive Officer Albert Bourla said that vaccines are harder to get approved right now as Health Secretary Robert F. Kennedy Jr. looks to overhaul the country’s immunization policies.
Pfizer stock (NYSE: PFE) is currently in a significant slump, marking its ninth consecutive day of decline and losing a total of −11% of its value over that period. This sustained sell-off has wiped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results